Record date for distribution of warrants of series TO 4 to current shareholders is set for October 29, 2020

This press release is an English version of the previously published Swedish version, which has interpretative preference.

As previously announced, the Board of Directors of Smoltek Nanotech Holding AB (”Smoltek” or the ”Company”) has resolved to distribute warrants of series TO 4 free of charge to the current shareholders in the Company. The record date for allotment to existing shareholders is now set for October 29, 2020.

As previously announced through press release on October 20, 2020, the Board of Directors of Smoltek has resolved to carry out a directed issue of units consisting of shares and warrants of series TO 4 (the “Directed Issue”). The investors in the Directed Issue have consisted of qualified investors. In order to provide current shareholders with the opportunity to, partially, be compensated for the dilution that arise from the shares and warrants of the Directed Issue, the Board of Directors of Smoltek resolved to, at the same time as the Directed Issue, issue an additional 621,347 warrants of series TO 4 (i.e. the same series as in the Directed Issue). The Company will allocate the additional warrants free of charge to current shareholders in the Company on the applicable record date.

The record date to receive warrants of series TO 4 has been set for October 29, 2020. The last day of trading in the Company’s share including the right to receive warrants is October 27, 2020, and the first day of trading in the Company’s share excluding the right to receive warrants of TO 4 is October 28, 2020.

Shareholders in Smoltek will receive one (1) warrant of series TO 4 for every eleven (11) held shares on the record date. Round down will be applied.

Additional terms for the warrants of series TO 4, as well as further information about the Directed Issue and the allotment of warrants to existing shareholders is evident from the relevant press release published by the Company on October 20, 2020.

The Company has the intention to ensure that all warrants of series TO 4 will be admitted for trading on Spotlight Stock Market.

Advisor
Mangold Fondkommission AB is the sole bookrunner and financial advisor and MAQS Advokatbyrå is the legal advisor in connection with the Directed Issue and allotment of warrants to existing shareholders in Smoltek.

For further information:  
Anders Johansson, CEO of Smoltek Nanotech Holding AB, 
E-Mail: anders@smoltek.com 
Telephone: +46 708-39 36 93 

Smoltek is developing process technology and concepts for applications based on carbon nanotechnology, primarily for the global semiconductor industry. Smoltek’s unique technology enables the production of semiconductor components with smaller form factors, higher performance and lower energy consumption.  
The company protects its unique technology through an extensive and growing IP-portfolio, consisting of about 100 applied patents, of which 62 are currently granted.  
Smoltek's applications are today mainly focused on the market segment for ”advanced packaging”, which is expected to grow at an average annual growth rate (CAGR) of 8.0 percent during the period 2018-2024 and achieve a market value of USD 43.6 billion in 2024 (source: Yole Développement Market research).Smoltek's share is listed on the Spotlight Stock Market in Stockholm, Sweden with the ticker symbol: SMOL. 
This press release is an English version of the previously published Swedish version, which has interpretative preference.